ARCHIVES

New Compounds To Treat Gleevec-Resistant CML

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Long-time NCI Spokesman Paul Van Nevel Dies at 75

August 9, 2013

President’s Budget Takes Care If R01s, P01s, Fattens Up NTP, Devastates Construction Grants

February 1, 1980

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

Congressional Committees Add Provisions To Cancer Act Renewal Bills To Strengthen NCI’s Independence, Prevent Fund Withholding

March 8, 1974